Therapeutische Behandlung der minimalen Resterkrankung zur Verhinderung von Spätrezidiven bei Hormonrezeptor-positivem Brustkrebs: Herausforderungen und neue Ansätze
Year: 2022
Type: article
Source: Kompass Onkologie
DOI: 10.1159/000524876
Institutions: University Health Network, Princess Margaret Cancer Centre, Emory University, Winship Cancer Institute, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Johns Hopkins University, University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Atrium Health Wake Forest Baptist, Wake Forest Baptist Comprehensive Cancer Center, Wake Forest University, Abramson Cancer Center, University of Pennsylvania
Language: German
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4281478661
